CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +53,812 | 53,812 | ||
| 2022-06-07 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +3,479 | 3,479 | ||
| 2022-06-07 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +3,711 | 3,711 | ||
| 2022-06-07 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +53,812 | 53,812 | ||
| 2022-06-07 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +2,319 | 2,319 | ||
| 2022-03-30 | Brady Todd C President and CEO | Grant or award | +250,000 | 1,198,835 | ||
| 2022-03-30 | Brady Todd C President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-03-30 | Brady Todd C President and CEO | Grant or award · Bonus Units | +207,758 | 207,758 | ||
| 2022-03-30 | Reed Joshua Chief Financial Officer | Grant or award | +93,322 | 274,825 | ||
| 2022-03-30 | Reed Joshua Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-03-30 | Machatha Stephen Chief Development Officer | Grant or award | +64,395 | 87,658 | ||
| 2022-03-30 | Machatha Stephen Chief Development Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-06-08 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +13,534 | 13,534 | ||
| 2021-06-08 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2021-06-08 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +408 | 408 | ||
| 2021-06-08 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +13,534 | 13,534 | ||
| 2021-06-08 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +1,167 | 1,167 | ||
| 2021-06-08 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +875 | 875 | ||
| 2021-06-08 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +13,534 | 13,534 | ||
| 2021-06-08 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +583 | 583 |
Page 8 of 19 · 376 trades